Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Medtronic PLC

MDT
84,33
1,99 (2,42%)
08 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/6/202418:50PRNUSMedtronic chairman and CEO Geoff Martha to speak at Goldman..
06/6/202416:22EDGAR2Form CERT - Certification by an exchange approving..
04/6/202422:37EDGAR2Form 8-K - Current report
03/6/202412:57PRNUSMedtronic announces closing of public offering of €3.0..
03/6/202412:51EDGAR2Form 8-K - Current report
29/5/202423:10PRNCAMedtronic announces pricing of €3.0 billion of senior notes
29/5/202422:12EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
23/5/202422:17EDGAR2Form SD - Specialized disclosure report
23/5/202413:35IHMARKETNEWSU.S. Futures Rise, Oil Prices Climb
23/5/202412:47EDGAR2Form 8-K - Current report
23/5/202412:45PRNCAMedtronic reports full year and fourth quarter fiscal 2024..
20/5/202416:54PRNCAMiniMed™ 780G system recognized among Fast Company's 2024..
20/5/202414:31PRNUSEuroPCR: Medtronic Evolut™ TAVR Platform Demonstrates..
17/5/202422:31PRNUSMedtronic Affera™ Mapping and Ablation System with Sphere-9™..
17/5/202417:35PRNUSLate-breaking data show reliable performance of..
09/5/202414:45PRNUSMedtronic to announce financial results for its fourth..
26/4/202413:56PRNCAMedtronic receives FDA approval for Inceptiv™ closed-loop..
17/4/202413:02PRNUSAmericans favor quality over quantity in pursuit of..
10/4/202414:30PRNCAMedtronic unveils the future of AI in GI: Genius Summit 2024..
08/4/202414:00PRNCAThe Medtronic Sphere-360™ Pulse Field Ablation (PFA)..
07/4/202415:45PRNCASMART trial one-year data demonstrates Medtronic Evolut™..
07/4/202414:00PRNUSNew survey uncovers lack of awareness around heart valve..
27/3/202413:00PRNCAMedtronic announces FDA approval of newest-generation Evolut..
21/3/202419:51PRNUSU.S. Patent Office rejects Axonics' latest challenge to..
09/3/202411:40PRNUSNew real-world data shows MiniMed™ 780G system sustains..
07/3/202422:20PRNUSMedtronic announces cash dividend for fourth quarter of..
07/3/202420:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:30PRNUSMedtronic EVP & CFO Karen Parkhill to participate in the..
29/2/202415:00PRNUSMedtronic files ITC action against Axonics to stop..
27/2/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
21/2/202419:23EDGAR2Form 144 - Report of proposed sale of securities
20/2/202412:47EDGAR2Form 8-K - Current report
20/2/202412:45PRNCAMedtronic reports third quarter fiscal 2024 financial..
20/2/202411:37IHMARKETNEWSMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil..
14/2/202422:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202413:15PRNCAMedtronic to announce financial results for its third..
02/2/202420:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202417:47DJNMedtronic on Track for Longest Winning Streak Since February..
08/1/202418:38PRNUSFDA approves Medtronic Percept™ RC neurostimulator with..
08/1/202412:45PRNUSMedtronic Diabetes announces world's first approval for..
05/1/202412:45PRNUSMedtronic receives CE Mark for its next generation Micra..
18/12/202323:35PRNUSMedtronic Chairman and CEO Geoff Martha to speak at J.P...
14/12/202300:51DJNMedtronic Gets New FDA Approval For Heart Condition..
14/12/202300:03PRNUSMedtronic creates history with FDA approval of its novel..
12/12/202320:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202320:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202307:00PRNUSMedtronic and Cosmo Pharmaceuticals forge ahead in AI-driven..
08/12/202322:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/12/202322:17PRNUSMedtronic announces cash dividend for third quarter of..
06/12/202323:11DJNMedtronic Terminates Acquisition of EOFlow, Citing Breaches..
Apertura: 82,65 Min: 82,6261 Max: 84,22
Chiusura: 82,34

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network